NCT02992743 2023-04-11Letetresgene Autoleucel Engineered T Cells in NY-ESO-1 Positive Participants With Advanced Myxoid/ Round Cell LiposarcomaGlaxoSmithKlinePhase 2 Completed23 enrolled 25 charts